ISMP identified the most commonly reported errors and hazards associated with the new COVID-19 vaccines.
The Institute for Safe Medication Practices (ISMP) provided safe practice recommendations for the administration of new coronavirus disease 2019 (COVID-19) vaccines following numerous reports of errors or hazards.1
Missteps identified in the reports included dilution errors, vaccine and monoclonal antibody mix-ups, waste of doses, administration to wrong age group, second dose scheduling errors, and allergic reactions.1
As of January 15, 2021, approximately 12.2 million individuals have received the first dose of a COVID-19 vaccine and about 31.1 million doses have been distributed in total.2 In recent weeks, the Trump administration urged states to expand vaccination eligibility to those 65 and older and those with underlying health conditions. President-elect Joe Biden also recently announced his COVID-19 plan, which includes a goal of administering 100 million vaccines by the hundredth day of his presidency.
According to ISMP, the main categories of errors being reported so far with the Pfizer-BioNTech and Moderna COVID-19 vaccines include1:
Other reported errors include a misspelling in an email address that resulted in the patient not receiving information on appointment to receive a second vaccine dose, the vaccination of underage patients, and serious but not life-threatening allergic responses.
To help reduce risk, ISMP offered recommendations for health care organizations1:
Read ISMP’s full article on COVID-19 vaccine errors.